| Treatment with tyrosine kinase inhibitors in patients with metastatic renal ... - UroToday |
|
|
UroTodayMulti-targeted tyrosine kinase inhibitors (MTKIs) are the standard in the treatment of metastatic renal cell carcinoma (mRCC). ... read more |